Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASF-1075 cream 5% for pruritus in adult patients with atopic dermatitis
2007-003212-65Phase 2Completed
- Sponsor
- Astion Pharma
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing ASF-1075 cream 5% with Vehicle control (2 arms). Primary endpoint: Pruritus due to atopic dermatitis. Started Jul 2007; status: completed.
02
Drugs
ASF-1075
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2007-003212-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003212-65.